The reversal of anticholinergic intoxication in man with the cholinesterase inhibitor VX.
D000931:Antidotes; D001561:Benzilates / Q000097:blood; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D002802:Cholinesterases / Q000097:blood; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D008297:Male; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000506:poisoning*; D010919:Placebos; D011041:Poisoning / Q000188:drug therapy; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D011812:Quinuclidines / Q000506:poisoning; D012601:Scopolamine / Q000506:poisoning; D013997:Time Factors
D000931:Antidotes; D001561:Benzilates; D002800:Cholinesterase Inhibitors; D009946:Organothiophosphorus Compounds; D010276:Parasympatholytics; D010919:Placebos; D011220:Pralidoxime Compounds; D011437:Propylamines; D011812:Quinuclidines; D012601:Scopolamine; D002802:Cholinesterases